DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 163 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $150 | +2.7% | 11,747 | +13.7% | 0.00% | – |
| Q2 2023 | $146 | -98.4% | 10,333 | -98.3% | 0.00% | -100.0% |
| Q1 2023 | $9,266 | -9.5% | 599,675 | -4.0% | 0.00% | -50.0% |
| Q4 2022 | $10,242 | -99.9% | 624,887 | -12.8% | 0.00% | 0.0% |
| Q3 2022 | $13,261,000 | +587.1% | 716,757 | +388.3% | 0.00% | – |
| Q2 2022 | $1,930,000 | -36.6% | 146,799 | -52.9% | 0.00% | – |
| Q4 2021 | $3,045,000 | -80.0% | 311,669 | -30.6% | 0.00% | -100.0% |
| Q3 2021 | $15,260,000 | -19.7% | 449,099 | -13.5% | 0.00% | -50.0% |
| Q2 2021 | $19,011,000 | -63.7% | 519,276 | -55.6% | 0.00% | -60.0% |
| Q1 2021 | $52,385,000 | -21.9% | 1,168,268 | -0.6% | 0.01% | -28.6% |
| Q4 2020 | $67,051,000 | +9.9% | 1,174,892 | -1.2% | 0.01% | 0.0% |
| Q3 2020 | $61,021,000 | -33.6% | 1,189,487 | -22.7% | 0.01% | -41.7% |
| Q2 2020 | $91,891,000 | +51.2% | 1,538,700 | +4.3% | 0.01% | +20.0% |
| Q1 2020 | $60,760,000 | -42.3% | 1,475,821 | -12.7% | 0.01% | -28.6% |
| Q4 2019 | $105,277,000 | +552.3% | 1,691,469 | +255.7% | 0.01% | +600.0% |
| Q3 2019 | $16,139,000 | – | 475,504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |